Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Travel Awards - Institute Community Support

University of British Columbia

$1,000.00

Diagnostic criteria, prevalence, and outcome of unclassifiable interstitial lung disease: A systematic review and meta-analysis.

FY 2017-18

Summary
Interstitial lung disease (ILD) is a heterogeneous group of inflammatory and fibrotic lung disorders that damage the lung parenchyma and cause dyspnea, functional limitation, and premature death. Some patients cannot be provided with a confident specific ILD diagnosis despite an exhaustive search for potential etiologies and a multidisciplinary review and consequently are labelled with unclassifiable ILD. Patients with unclassifiable ILD are frequently included in clinical studies, however these patients are not well characterized and there is no systematic review summarizing the current evidence on so far.
Program
Travel Awards - Institute Community Support
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
368482
Name
Guler Sabina A
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Health systems / services
Prcname2
Institute of Circulatory and Respiratory Health
Projecttitle
Diagnostic criteria, prevalence, and outcome of unclassifiable interstitial lung disease: A systematic review and meta-analysis.
Programtype2
Undefined
Orgnameinp2
University of British Columbia
Cihramount2
$1,000
Cihrequipment2
$0
Programname2
Travel Awards - Institute Community Support
Keyworddelim
Ics Travel Awards
Abstract
Interstitial lung disease (ILD) is a heterogeneous group of inflammatory and fibrotic lung disorders that damage the lung parenchyma and cause dyspnea, functional limitation, and premature death. Some patients cannot be provided with a confident specific ILD diagnosis despite an exhaustive search for potential etiologies and a multidisciplinary review and consequently are labelled with unclassifiable ILD. Patients with unclassifiable ILD are frequently included in clinical studies, however these patients are not well characterized and there is no systematic review summarizing the current evidence on so far.
Competitiondate
201707
Approvedterm2
1 yr 0 mth
Pinamesdelim
Guler, Sabina A
Approvedterm
1 an 0 mois
Cihrcontribution2
Inst of Circ &Respiratory Hlth~ $1,000~ $0~
University of British Columbia - $1,000 Grant (2017-1… | Canada Spends